Initial studies assessing the role of PKC in CLL cells utilized reagents such as the macrocyclic lactone bryostatin and the phorbol ester PMA, which globally modulate PKC activities and signalling pathways. Here, PRRT2 is linked to B-cell chronic lymphocytic leukemia.